Department of Respiratory Medicine, Chinese People's Liberation Army General Hospital, Beijing, China.
Chin Med J (Engl). 2013 Jul;126(14):2725-30.
Hospitalized patients often have higher rate of vitamin D deficiency than healthy people. Vitamin D levels below normal are associated with hospital stay, increased incidence of adverse prognosis and increased mortality of a number of diseases. Whether there is a relationship between vitamin D levels and infection or sepsis in the critically ill is still unclear. This study will explore the relationship between vitamin D levels and risk of infection, assessment for disease severity, and predictor of mortality.
To evaluate the value of vitamin D in intensive care unit (ICU) cases to sepsis, severity and prognosis assessment, high performance liquid chromatography and tandem mass spectrometry were used to measure the concentrations of vitamin D in sera of critically ill patients. The serum samples were drawn within the first 24 hours of ICU admission.
The study included 206 people, 50 healthy controls, 51 ICU control patients and 105 ICU diagnosed with sepsis. Critically ill ICU patients (ICU sepsis and ICU control group) had lower vitamin D concentration than normal people, but septic patients showed no significant reduction of vitamin D concentration when compared with critically ill patients with no positive etiological evidence. For assessment of disease severity, there were very low negative correlations between APACHE II, SAPS II and SOFA scores and vitamin D level. Additionally, patients of different 25-(OH)D levels showed no difference whether in terms of 28-day survival (X(2) = 1.78, P = 0.776) or 90-day survival (X(2) = 4.12, P = 0.389). Multivariate Logistic regression demonstrated that APECHE II and SAPS II scores were independent risk factors to deaths caused by sepsis.
Clinically, serum concentration of vitamin D is not an indicator for diagnosis and assessment in critically ill patients (ClinicalTrial.gov identifier NCT01636232).
住院患者的维生素 D 缺乏率往往高于健康人群。维生素 D 水平低于正常值与住院时间延长、不良预后发生率增加以及多种疾病的死亡率增加有关。危重病患者的维生素 D 水平与感染或脓毒症之间是否存在关系尚不清楚。本研究将探讨维生素 D 水平与感染风险、疾病严重程度评估和死亡率预测之间的关系。
为评估维生素 D 在重症监护病房(ICU)患者中对脓毒症、严重程度和预后评估的价值,采用高效液相色谱串联质谱法测定危重病患者血清中维生素 D 的浓度。血清样本于 ICU 入院后 24 小时内采集。
本研究共纳入 206 人,其中 50 名健康对照者、51 名 ICU 对照组患者和 105 名 ICU 诊断为脓毒症的患者。与正常人相比,危重病 ICU 患者(ICU 脓毒症和 ICU 对照组)的维生素 D 浓度较低,但与无明确病因证据的无脓毒症危重病患者相比,脓毒症患者的维生素 D 浓度并无显著降低。在评估疾病严重程度方面,APACHE II、SAPS II 和 SOFA 评分与维生素 D 水平之间呈极低的负相关。此外,不同 25-(OH)D 水平的患者在 28 天生存率(X(2) = 1.78,P = 0.776)或 90 天生存率(X(2) = 4.12,P = 0.389)方面均无差异。多因素 Logistic 回归分析表明,APACHE II 和 SAPS II 评分是脓毒症死亡的独立危险因素。
临床上,血清维生素 D 浓度不是危重病患者诊断和评估的指标(ClinicalTrial.gov 标识符 NCT01636232)。